M1 and M2 macrophage recruitment during tendon regeneration induced by amniotic epithelial cell allotransplantation in ovine  by Mauro, Annunziata et al.
Research in Veterinary Science 105 (2016) 92–102
Contents lists available at ScienceDirect
Research in Veterinary Science
j ourna l homepage: www.e lsev ie r .com/ locate / rvscM1 and M2 macrophage recruitment during tendon regeneration
induced by amniotic epithelial cell allotransplantation in ovineAnnunziata Mauro a,b, Valentina Russo a,b,⁎, Lisa Di Marcantonio a, Paolo Berardinelli a, Alessandra Martelli a,
Aurelio Muttini a,b, Mauro Mattioli a, Barbara Barboni a,b
a Faculty of Veterinary Medicine, University of Teramo, Campus Universitario Coste S. Agostino Via R. Balzarini 1, 64100 Teramo, Italy
b StemTeCh Group, Italy⁎ Corresponding author at: Faculty of Veterinary Medic
S. Agostino Via R. Balzarini 1, 64100 Teramo, Italy.
E-mail address: vrusso@unite.it (V. Russo).
http://dx.doi.org/10.1016/j.rvsc.2016.01.014
0034-5288/© 2016 The Authors. Published by Elsevier Ltda b s t r a c ta r t i c l e i n f oArticle history:
Received 24 June 2015
Received in revised form 25 November 2015
Accepted 19 January 2016Recently, we have demonstrated that ovine amniotic epithelial cells (oAECs) allotransplanted into experimental-
ly induced tendon lesions are able to stimulate tissue regeneration also by reducing leukocyte inﬁltration.
Amongst leukocytes, macrophages (Mφ) M1 and M2 phenotype cells are known to mediate inﬂammatory and
repairing processes, respectively. In this research it was investigated if, during tendon regeneration induced by
AECs allotransplantation, M1Mφ and M2Mφ phenotype cells are recruited and differently distributed within
the lesion site. Ovine AECs treated and untreated (Ctr) tendons were explanted at 7, 14, and 28 days and tissue
microarchitecture was analyzed together with the distribution and quantiﬁcation of leukocytes (CD45 positive),
Mφ (CD68 pan positive), and M1Mφ (CD86, and IL12b) and M2Mφ (CD206, YM1 and IL10) phenotype related
markers. In oAEC transplanted tendons CD45 and CD68 positive cells were always reduced in the lesion site. At
day 14, oAEC treated tendons began to recover their microarchitecture, contextually a reduction of M1Mφ
markers, mainly distributed close to oAECs, and an increase of M2Mφmarkers was evidenced. CD206 positive
cells were distributed near the regenerating areas. At day 28 oAECs treated tendons acquired a healthy-like struc-
ture with a reduction of M2Mφ. Differently, Ctr tendons maintained a disorganized morphology throughout the
experimental time and constantly showed high values ofM1Mφmarkers. These ﬁndings indicate that M2Mφ re-
cruitment could be correlated to tendon regeneration induced by oAECs allotransplantation. Moreover, these re-
sults demonstrate oAECs immunomodulatory role also in vivo and support novel insights into their allogeneic use
underlying the resolution of tendon ﬁbrosis.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Tendon injuries are a common cause of disease and represent a sig-
niﬁcant health liability on society. Tendons can be exposed to trauma
during sports activities, but they can also be affected by overuse or
aging. The most commonly injured are Achilles and patellar tendons
with pathologies ranging from degenerative tendinopathies, partial
tears, up to complete ruptures (Jarvinen et al., 2005; Sharma and
Maffulli, 2005; Duerden and Keeling, 2008). Horses suffer tendinitis of
the superﬁcial digital ﬂexor tendon (SDFT), which is a signiﬁcant
cause of lameness and often a career-ending event in thoroughbred
horses because of its high incidence, prolonged recovery period, and
high rate of recurrence. These injuries are difﬁcult to manage because
tendons do not regenerate spontaneously, but originate a ﬁbrotic scar
with poor tissue quality andmechanical properties, frequently resultingine, Campus Universitario Coste
. This is an open access article underin long-term pain, discomfort, and disability (Sharma and Maffulli,
2005; Sharma andMaffulli, 2006). Given the frequency and the increas-
ing cost of treating injuries, as well as the relatively poor results obtain-
ed through surgical intervention, new and innovative cell-based
therapies have become more appealing. Multipotent stem cells, termed
tendon stem/progenitor cells (TDSCs/TSPCs), are present in tendons
and ligaments (Bi et al., 2007; Ni et al., 2012), but they appear to be in-
sufﬁcient to sustain tendon regeneration in adults (Ruzzini et al., 2013).
Moreover, the collection of TDSCs/TSPCs results very difﬁcult for donor
site morbidity (Ruzzini et al., 2013). Other stem/progenitor cells have
been studied (Chong et al., 2009; Chen et al., 2011; Clarke et al., 2011;
Young, 2012; Lange-Consiglio et al., 2013). In this context, in recent
years amniotic-derived cells have attracted increasing attention as an
alternative source of stem/progenitor cells for clinical application in re-
generative medicine (Parolini et al., 2009; Malek and Bersinger, 2011;
Miki, 2011; Barboni et al., 2012a; Mamede et al., 2012; Barboni et al.,
2013; Colosimo et al., 2013; Murphy and Atala, 2013). In particular,
ovine amniotic membrane-derived epithelial cells (oAECs) have been
largely investigated for their regenerative tendon ability after allo-the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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(Muttini et al., 2013) into experimentally induced tendon injuries. The
results in Barboni et al. (2012a) demonstrated oAECs ability to support
tendon regeneration with a prompt recovery of the biomechanical
properties of the tissue. Indeed, in a previous paper (Barboni et al.,
2012a)we have demonstrated that oAECs induced tendon regeneration
through the modulation into the host tissue of crucial growth factors
(i.e., VEGF and TGFβ1), and thanks to a large production of collagen
type I (COL1) ﬁbers deposited either by the recruited host tissue pro-
genitor cells or directly by transplanted oAEC. In the host-injured tissue,
some oAECs differentiated into tenocyte-like cells switching on, simul-
taneously, COL1 (Barboni et al., 2012a). In addition, oAEC allotransplan-
tation promoted a speciﬁc and centripetal process of tissue regeneration
that began close to the healthy portion of the tissue and then progres-
sively invaded the core of the wound site, where oAECs rapidly migrat-
ed (Barboni et al., 2012a).
Amongst the crucial regenerating processes are anti-inﬂammatory/
immunomodulatory effects (Parolini et al., 2009; Barboni et al., 2014;
Magatti et al., 2014). Indeed, oAECs induced a reduction of leukocyte in-
ﬁltration also in injured tendons (Barboni et al., 2012a). This AEC in vivo
effect could be attributed to the innate immunomodulatory activities
demonstrated in vitro (Parolini et al., 2008; Banas et al., 2008; Miki,
2011; Mattioli et al., 2012; Barboni et al., 2014) and could explain the
use of these cells into allo- and xeno-transplantation settings
(Cargnoni et al., 2009; Magatti et al., 2009; Barboni et al., 2012a;
Muttini et al., 2013). However, the complex mechanisms involved in
the in vivo immunoregulatory functions of AECs are not fully under-
stood. The immunomodulatory effect on T and B lymphocytes
(Barboni et al., 2014; Magatti et al., 2014) has been described, but new
attention is now paid on their potential effects on macrophages (Mφ).
Mφ play a crucial role in the resolution of tissue injury and promotion
of tissue repair as described in several human diseases (Brancato and
Albina, 2011). In response to chemotactic signals, monocytes migrate
into tissues and subsequently differentiate into Mφ to replace aged
ones or to participate in the initial phases of tissue defense in reaction
to harmful insults (Murray and Wynn, 2011; Svensson et al., 2011).
Mφ also play an essential role in the later phases of tissue homeostasis
and repair phagocytazing apoptotic cells (Murray and Wynn, 2011).
The origin and activation state of Mφ and their microenvironment are
critical determinants of their response to injury. Functionally, Mφ can
be polarized into distinct subpopulations, with speciﬁc functions related
to the initiation and recovery phases of tissue injury (Murray andWynn,
2011). Typically, Mφ are classiﬁed into two main groups: classically-
activated Mφ (M1Mφ) and alternatively-activated Mφ (M2Mφ)
(Gordon and Martinez, 2010; Murray and Wynn, 2011). M1Mφ are
pro-inﬂammatory cells with potent anti-microbial activities and pro-
mote T helper 1 (Th1) cell responses and have also been implicated in
many inﬂammatory diseases (Murray and Wynn, 2011). Conversely,
M2Mφ are immunosuppressive cells that can support T helper 2
(Th2)-associated effector functions. M2Mφ are characterized by their
low production of pro-inﬂammatory cytokines (i.e. IL1ß and IL12) and
high production of anti-inﬂammatory cytokines (i.e. IL10) (Gordon
and Martinez, 2010; Murray and Wynn, 2011). In particular, M2Mφ
play a major role in the resolution of inﬂammation, tissue remodeling
and wound repair by releasing IL10, secreting trophic factors and en-
hancing the clearance of apoptotic cells (Gordon and Martinez, 2010;
Murray and Wynn, 2011).
Recent evidence starts to focus attention on Mφ-mediated mecha-
nisms during cell-based preclinical approaches. Indeed, it has been
shown that human placental mesenchymal stem cells (pMSCs) express
their immunomodulatory role shifting M1 towards M2-like Mφ
(Abumaree et al., 2013). In addition, human AEC-conditioned media al-
tered bone marrow-derived Mφ polarization, migration, and phagocy-
tosis, without affecting Mφ survival or proliferation in vitro. Similarly,
hAECs mediated lung repair directly inﬂuencing Mφ behavior in a pro-
reparative manner in vivo (Tan et al., 2014). In naturally occurringtendon injuries, Dakin et al. (2012) investigated the contribution of dif-
ferentMφ subsets in an equinemodel. These authors have demonstrat-
ed that the pro-inﬂammatoryM1Mφ predominated in sub-acute injury,
whereas a potential phenotype-switch to M2Mφ polarity was seen in
the chronic phase of injury (Dakin et al., 2012).
Based on the assumption of the crucial role of Mφ population in tis-
sue resolution described in the literature, the present research was de-
signed to investigate Mφ inﬁltration after oAECs allotransplantation
into a validated preclinical tendon regenerative model (Barboni et al.,
2012a). In particular, it was investigated if pro-inﬂammatory M1Mφ
and pro-regenerative M2Mφ phenotype were recruited and if they
were differently distributed within the lesion site during the early
phases of the repair process induced by oAECs allotransplantation. The
experiments were carried out on an ovine model chosen for its high
translational value for musculoskeletal regenerative horse and human
pathologies (Wagner and Storb, 1996; Bruns et al., 2000; Wang, 2006;
McCarty et al., 2009).
2. Materials and methods
2.1. Ethic statement
The Ethical Committee CEISA of the University of Chieti and Teramo
has approved all experimental procedures (approval ID 27/2010/CEISA/
COM of 11/11/2010). Eighteen Appenninica breed sheep, two years old
with ameanweight of 40 kg, were used. The sheepwere bred according
to the European community guidelines (E.D. 2010/63/UE) before
performing bilateral tendon lesions. Animals were quarantined for
2 weeks to check the general healthy status. Surgical procedures were
carried out under general anesthesia and in an authorized veterinary
hospital. The animals were randomly divided into three groups and eu-
thanized to explant grafted tendons at 7, 14, and 28 days. Animals were
euthanized by applying an overdose of thiopental (Pentothal Sodium,
Intervet) and embutramide (Tanax®, Intervet).
2.2. Ovine AECs isolation and labeling
Ovine AECs (oAECs) were collected from slaughtered sheep of
Appenninica breed at 3 months of pregnancy (25–30 cm of length).
The cells were obtained from the isolated amniotic epithelial layer
after enzymatic digestion (Trypsin–EDTA, Sigma Chemical Co., St.
Louis, MO, USA) as previously described by Barboni et al. (2012a).
Brieﬂy, cell suspensions were seeded in ﬂasks in minimum essential
medium Eagle-α modiﬁcation (α-MEM) supplemented with 20%
fetal calf serum (FCS), 1% ultraglutamine, 1% penicillin/streptomycin
plus 10 ng/ml epidermal growth factor (EGF) at a concentration of
3 × 103 cells/cm2. At 70% conﬂuence, the cells were dissociated by
0.05% trypsin–EDTA and frozen in α-MEM containing 20% FCS and
10% dimethyl sulfoxide (DMSO). Thawed cells were plated again at
3 × 103/cm2 for three consecutive passages. Ovine AEC morphology
during the in vitro culture was analyzed with an inverted microscope,
whereas Cytokeratin 8 expression was evaluated using the monoclonal
anti-Cytokeratin 8 primary antibody (1 μg/ml; Abcam, Cambridge, UK)
and an anti-mouse Alexa Fluor 488 (2 μg/ml; Invitrogen Ltd., Paisley,
UK) secondary antibody for its retrieval by immunocytochemistry as
described in our previous report (Barboni et al., 2012b). The prolifera-
tive activity was analyzed by calculating in triplicate oAECs doubling
time (total number of cells/plate every 24 h) starting from day 0 to
day 4 of culture. oAEC molecular characterization were performed by
ﬂow cytometry investigations, as previously described in our reports
(Mauro et al., 2010; Barboni et al., 2012a; Mattioli et al., 2012;
Barboni et al., 2014) for haemopoietic markers (CD14, CD58, CD31 e
CD45), surface adhesion molecules (CD29, CD49f and CD166), stem
cell markers (TERT, SOX2, OCT4, NANOG), for MHC class I molecule
and MHC class II (HLA-DR) antigens. Details of speciﬁc antibodies
used and ﬂow cytometry procedures have been previously described
Table 1
Antibodies used for IHC.
Primary abs Secondary abs
μg/ml μg/ml
CD45 (AbD Serotec, Oxford, UK) 0.5 Anti-mouse-FITC (Sigma-Aldrich, Missouri,USA) 5
CD68 (Dako, Glostrup, Denmark) 5 Anti-mouse Alexa Fluor 488 (Invitrogen Ltd., Paisley, UK) 2
CD86 (Serotec, Gibbstown, NJ) 0.02 Anti-mouse Alexa Fluor 488 (Invitrogen Ltd., Paisley, UK) 5
CD206 (R&D System Cambridge, UK) 4 Anti-mouse FITC (Sigma-Aldrich, Missouri,USA) 5
COL1 (Chemicon Int. Billrerica, USA) 1 Anti-mouse Alexa Fluor 488 (Invitrogen Ltd., Paisley, UK) 2
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et al., 2014). Then, 2.5 × 106 oAECs were stored in liquid nitrogen in
vials. Before transplantation, thawed oAECs were stained with the
red ﬂuorescent cell linker dye PKH26, according to manufacturer's in-
structions (Sigma) as previous described (Barboni et al., 2012a and
Barboni et al., 2012b; Muttini et al., 2013; Barboni et al., 2013). The
PKH26 dye stably incorporates into lipid regions of the cell membrane.
Due to this extremely stable ﬂuorescence, PKH26 is the linker dye of
choice for in vivo cell tracking and monitoring studies (http://www.
sigmaaldrich.com/technical-documents/articles/biowire/cell-tracking.
html; https://www.sigmaaldrich.com/content/dam/sigma-ldrich/docs/
Sigma/Bulletin/mini26bul.pdf).
Brieﬂy, thawed oAECs cells were re-suspended in 1 ml of Diluents C
and then added at 1 ml of Dye Solution containing 4 μl of PKH26. The
cellular suspension was incubated for 5 min at room temperature
with periodic mixing. Cells staining was stopped with 2 ml of 1% PBS/
BSA for 1 min and ﬁnally centrifuged at 400 ×g for 10 min. Cells were
suspended and counted in order to obtain 4 × 106 PKH26–marked
oAECs vital cells to be used for transplantation.
2.3. Surgical procedure and oAECs transplantation technique
The experimental surgical procedure was performed as previously
described by Barboni et al. (2012a). Under general anesthesia, the pelvic
limbs of the animals were placed off with both tarsi under ﬂexion. A
3 cm skin incision was made, starting at 4 cm proximal to the tuber
calcis. The medial and more prominent component of the Achilles ten-
don, that is, the tendon ofm. ﬂexor digitorum superﬁcialis, was isolated.
Using a sterile punch, a full thickness hole, 3 mm in diameter, was real-
ized. Using a randomized pattern, the lesion of one limb was ﬁlled with
a total volume of 30 μl composed of a suspension containing 4 × 106
oAECs-PKH26 labeled cells plus ﬁbrin glue (1:1, v/v; Tissucol; Baxter
Spa) (oAECs treated tendon), while the contralateral lesion was ﬁlled
with ﬁbrin glue alone (Ctr tendon) (Awad et al., 2003; Hoffmann
et al., 2006; Hou et al., 2009a and Hou et al., 2009b; Barboni et al.,
2012a). The paratenon and fascia were closed before skin suture. After
surgery animals were kept in a small holding corral until sacriﬁce. Ani-
mals and surgical wounds were inspected daily. Eighteen animals were
randomly divided amongst the three time points, 7, 14, and 28 days, in
order to process the tendon explants, Ctr and oAEC treated tendons, for
themorphological andmolecular analyses. Animalswere euthanized by
applying thiopental (Pentothal Sodium, Intervet) and embutramide
(Tanax®, Intervet).
2.4. Morphological and immunohistochemical analysis
Ctr and oAECs explanted tendons at 7, 14, and 28 days after
transplantation, were transversally cut at least 5 mm from the in-
jured area. The specimens were placed in liquid nitrogen. Cryosec-
tions, 7 μm in thickness, were processed with hematoxylin–eosin
(H&E) and immunohistochemistry (IHC) as described in our previous
report Barboni et al. (2012a). H&E stain was carried out to obtain in-
formation on the tissue cell concentration, microarchitectureregeneration and extracellular matrix reorganization, within the in-
jured tendons during the different interval points (7, 14, and
28 days) using a scoring system as previously reported in Barboni
et al. (2012a) slightly modiﬁed. Three different scores were adopted
to indicate:
– Score 1, a damaged tissue with cells showing rounded nuclei, and a
faint disorganized extracellular matrix;
– Score 2, an early stage of tendon healing showing cells with rounded
nuclei, an increased matrix deposition with ﬁbers acquiring a paral-
lel orientation;
– Score 3, an early stage of tendon regeneration with prevalent ﬂat
shaped cells and fusiform nuclei, an extracellular matrix character-
ized by oriented ﬁbers along the longitudinal axis of the healthy
tendon.
The IHC analyses were performed with the antibodies:
– monoclonal mouse anti sheep COL1 (Barboni et al., 2012a, 2012b) in
order to evaluate collagen Type I ﬁber deposition;
– monoclonal mouse anti sheep CD45 (MCA2220F) (Barboni et al.,
2014) in order to evaluate pan leukocytes;
– monoclonal mouse anti-human CD68 (clone EBM11) (Di Palma
et al., 2012) in order to evaluate pan Mφ inﬁltrations;
– monoclonal mouse anti-bovine CD86 (MCA2437GA, clone IL-A190)
(Neeland et al., 2014) in order to evaluate speciﬁc pro-
inﬂammatory M1Mφ cells;
– Polyclonal Goat IgG anti-human MMR/CD206 (AF2534) (Kuo et al.,
2011) in order to evaluate anti-inﬂammatory M2Mφ cells.
Detailed information on primary antibodies and on secondary anti-
bodies used for their retrieval are summarized in Table 1. Cell nuclei
were identiﬁed with DAPI. Primary antibodies were replaced with
non-immune sera as negative controls.
2.5. Morphometric analysis
Morphometric analyses were performed with an Axioscop 2plus
epiﬂuorescence microscope (Zeiss, Oberkochen, Germany) equipped
with a cooled color charge-coupled device camera (CCD; Axiovision
Cam, Zeiss) interfacedwith an interactive and automatic image analyzer
(Axiovision, Zeiss). The data were processed using a KS300 computed
image analysis system (Zeiss) and quantiﬁed as previously described
(Barboni et al., 2012a). Brieﬂy, guided programs (macros for KS300)
were created to count inside a standard area of 20,000 μm2: cell pres-
ence (total number of DAPI stained nuclei in the area), leukocyte inﬁl-
tration (% CD45-positive cells/total number of nuclei in the area), Mφ
inﬁltration (% CD68-positive cells/total number of nuclei in the area),
pro-inﬂammatory M1Mφ phenotype population (% CD86-positive
cells/total number of nuclei in the area), and anti-inﬂammatory
M2Mφ phenotype populations (% CD206-positive cells/total number
of nuclei in the area). Analyseswere carried out on at least ﬁve different
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group = 5). Morphometric analyses were performed at 200× magniﬁ-
cation by capturing ﬁve images from six contiguous areas starting from
the healthy zone (area 0) and proceeding throughout the repairing
zones for ﬁve consecutive areas (areas 1–5). The extension of each
zone analyzed was ~300 μm and, therefore, the total area analyzed
within each section was ~1800 μm (Barboni et al., 2012a).
Sections with retrieved PKH26-positive cells were immunostained,
as described above, for CD86 and CD206. Morphometric analyses were
adopted to evaluate the percentage of PKH26-positive cells that co-
localized with CD86 or with CD206 (CD86 or CD206 and PKH26
double-stained cells/total number of PKH26 cells). The morphometric
analyses were performed on at least ﬁve ﬁelds on all the consecutive
sections that displayed engrafted PKH26-positive cells.
2.6. Laser capture micro dissection (LCM) technique
Procedures for LCM were performed as previously reported in
Barboni et al. (2012a). Brieﬂy, the frozen sections were air-dried on un-
coated glass slides and washed with 70% ethanol. The sections were
kept on dry ice at−80 °C until they were subjected to LCM. Just before
the procedure, the sections were ﬁxed in 70% ethanol for 10 s and
stained with H&E according to Hoffmann et al. (2006). LCM were per-
formed by using a Laser Capture Micro dissection (MMI Cellcut device)
apparatus. The settings of the laser were performed as follows: spot di-
ameter 10 μm, pulse duration 50 ms; laser power 50 mW. The areas to
micro-dissect were identiﬁed under a light microscope at ×40 of mag-
niﬁcation including a portion of the implantation site within the host
tendon. Every section was dropped on a separate cap. Micro-dissected
sections (n = 30 sections)/sample were immediately processed for
RNA extraction and RT-PCR procedures.
2.7. RNA isolation and RT-PCR procedures
Total RNA was extracted from tendon micro-dissected cryosections
(n = 30 for each animal group/time) by TriReagent (Sigma) following
manufacturer's instruction as previous reported in Barboni et al.
(2012a). Agarose gel electrophoresis (1%) and ethidium bromide stain-
ing was used to evaluate RNA integrity. The RNA was treated with
DNaseI digestion (Sigma) for 15 min at RT. Total RNA (1 μg) of each
sample was used for reverse transcription reaction with the Oligo dT
primer and BioScriptTM (Bioline). 2× ready mixTM Taq PCR reactions
mix (Sigma) was used for PCR reaction using 3 μl of cDNA and 0.5 μM
of each primer in a ﬁnal volume of 25 μl. The PCR gene primers, mRNA
sequence GenBank number, product length, and cycles are shown in
Table 2. The reaction mixtures were incubated for 5 min at 95 °C,
followed by 95 °C for 30 s, 55 °C for 30 s, 72 °C for 45 s, and 72 °C
for 7 min. RT-PCR was normalized by the transcriptional levels of glyc-
eraldehyde 3-phosphate dehydrogenase (GAPDH). The PCR productsTable 2
Primer sequences used for RT-PCR.
Gene Accession no. Primer sequences Size (bp) Cycles
CD86 AY395982.3 F: AGAAGGTCCCAAGGACTGGT 387 40
Ovine R: GCTTGGCACAGGTGACTTTG
CD206 NM001197180.1 F: GTAGAAGCAGGCTGCCAGAA 394 40
Ovine R: CTTCTGCCCAGTGTTTGCAC
YM1 XM004013541.1 F: AGGACATCATAGCCCCCTGT 270 40
Ovine R: GCTCCGTGGAGGAAATCACA
IL10 NM001009327.1 F: CTGTGCCTCTCCCCTAGAGT 237 40
Ovine R: GCAGCTAGCTCCACAAGGAA
IL12b NM001009438.1 F: ACAAAGGAGGCGAGGTTCTG 283 40
Ovine R: CTGTGGTCCATGCTGACCTT
GAPDH AF030943.1 F: CCTGCACCACCAACTGCTTG 224 40
Ovine R: TTGAGCTCAGGGATGACCTTGwere separated on 2% agarose gel stained with ethidium bromide, vi-
sualized on a Gel Doc 2000 (Biorad), and analyzed with Quantity
One 1-D Analysis software (Biorad). Each reaction was carried out in
triplicate.
2.8. Statistical analysis
The quantitative data obtained, expressed as mean ± Standard
Error (±SE), were ﬁrstly assessed for distribution by D'Agostino and
Pearson tests. Data sets were compared using ANOVA tests followed,
when necessary, by posthoc Tukey tests (GraphPad Prism 5, GraphPad
Software, USA). The values were considered statistically signiﬁcant for
p b 0.05.
3. Results
3.1. oAECs culture, characterization and stain
According to our previous studies (Barboni et al., 2012a; Mattioli
et al., 2012; Muttini et al., 2013) ovine AECs showed, in in vitro culture,
a typical polyhedral phenotype characterized by the cytokeratin 8 epi-
thelial marker expression (Fig. 1A). Cells proliferated with an average
doubling time of 20–24 h and, showed the molecular proﬁle indicated,
by the ﬂow cytometry analysis (Fig. 1A). oAEC did not display any
haemopoietic markers (CD14, CD58, CD31 e CD45). On the contrary,
the cells expressed several surface adhesion molecules (CD29, CD49f
and CD166), and the stemness markers TERT, SOX2, OCT4 and
NANOG, while the CD117 resulted not expressed (Fig. 1A). Cells main-
tained all characteristics until third passage in culture also after freez-
ing and thawing cycles (Fig. 1A). The thawing procedures did not
inﬂuence cell vitality because oAECs remained healthy and were able
to incorporate the vital PKH26 red stain before transplantation
(Fig. 1Ba). Cells maintained the dye both in in vitro (Fig. 1Bb) and in
in vivo (Fig. 1Bc) experiments. Indeed, in explanted oAEC treated ten-
dons the recovery of red PKH26-labeled oAECs with healthy nuclei in-
dicate their stable integration in the tissues up to 28 days after
transplantation (Fig. 1Bc).
3.2. Microarchitecture tendon recovery
The tendon lesion site and PKH26-labeled oAECs injection proce-
dures were performed using a validated experimental technique
(Barboni et al., 2012a). Tendons were explanted at 7, 14 and 28 days
after transplantation. The defect area in tendon explants was macro-
scopically detected as a circle/irregular hemorrhagic zone localized in
the middle portion except in oAEC treated tendons at day 28 where it
appeared as a white opalescent zone with few hemorrhagic signs
(data not shown). The differences between Ctr and oAECs tissue
microarchitecture began to be evident at day 7 (Fig. 2Aa and Ad). In par-
ticular, tendon cell nuclei were entrapped within a still evident ﬁbrin
glue in Ctr (score 1, Fig. 2Aa), and into a faint and irregularly organized
extracellularmatrix in oAEC treated tendons (score 1, Fig. 2Ad). The tis-
sue remodelingprogressed rapidly in the presence of oAECs. At day 14, a
greater matrix deposition with ﬁbers acquiring a parallel orientation
and a prevalent presence of fusiform cell nuclei (score 2, Fig. 2Ae)
were recorded. At day 28, a higher extracellular matrix density and ori-
ented ﬁbers became evident within the healing area (score 3, Fig. 2Af).
On the contrary, rounded nuclei enclosed within a disorganized extra-
cellular matrix persisted into the wound area of Ctr tendons until day
28 (score 1, Fig. 2Ab and 2A c). According to our previous report
(Barboni et al., 2012a), COL1 was almost absent in the lesion site of
both tendons at day 7 and started to be present in oAECs treated ten-
dons after 14 days (data not shown). Then, after 28 days, COL1 was
expressed in allotransplanted sites as ﬁber-like wires presenting a den-
sity and orientation along the longitudinal axis of the tendon similarly
to the healthy portion of the tissue (Fig. 2Bb). On the contrary, COL1
Fig. 1.Molecular characterization of cultured and cryopreserved oAECs. (A). Representative images of in vitro cultured oAECs displaying a polyhedral phenotype (phase contrast) and
cytokeratin 8 positivity (green color). Nuclei were counterstained with DAPI (blue color). Scale Bar: 50 μm for all images. oAECs growth curve was established calculating the rate of
growth of cells every 24 h for 4 days (values are mean ± SD of 3 different experiments). The histogram indicates the molecular proﬁle of surface, MHC and pluripotency markers
expressed as Mean Fluorescence Intensity (MFI) ratio (values are mean ± SD of 3 different biological samples) levels obtained with ﬂow cytometry analysis. All analyses were carried
out on oAECs expanded in vitro for III passages, before and after freezing and thawing (Fr/Tw). (B). Representative images of PKH26-labeled oAECs (red color) after thawing and
labeling before transplantation (a), in in vitro culture after thawing and labeling (b) and in explanted tendons after 28 days transplantation (c). Nuclei were counterstained with DAPI
(blue color). Scale bar: 20 μm, 25 μm and 50 μm, respectively.
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dons at day 28 displaying a scattered random distribution throughout
the repairing site (Fig. 2Ba).
3.3. Cell, leukocyte and macrophage inﬁltration during tendon healing
The morphometric analysis of cell (Fig. 3A), leukocyte (Fig. 3B)
and macrophage inﬁltration (Fig. 3C) in Ctr and oAEC treated tendons
was carried out on tissue sections divided in six contiguous areas,
from the healthy zone (area 0) up to the core of the lesion (area 5),
at 7, 14, and 28 days after transplantation. PKH26-labeled oAECs
were always identiﬁed inside the defect area with a distribution
that was strictly dependent on the progression of tissue healing. At
day 7, oAECs rapidly migrated towards the healthy portion of the tis-
sue in the areas 1 and 2 (arrows in Fig. 3A). Then, they were recorded
at day 14 into the areas 3–4, and at day 28 into the areas 4–5 (arrows
in Fig. 3A).
Cellularity in oAEC treated tendons was signiﬁcantly higher in the
areas 1–2 at day 7 (Fig. 3A, p b 0.05), and in the areas 4–5 (Fig. 3A;
p b 0.05) at day 14. Then, cellularity decreased at day 28 becoming sig-
niﬁcantly lower in areas 2–4 than in Ctr (Fig. 3A, p b 0.05).
Inﬂammatory cell inﬁltration was evaluated using an anti CD45 an-
tibody, a pan leukocyte marker (Fig. 3B), an anti CD68 antibody, a pan
Mφ marker (Fig. 3C). CD45-positive cells were signiﬁcantly lower in
oAEC treated tendons at day 7 in the whole defect area, areas 1–5,
(Fig. 3B, p b 0.05) than in Ctr. Then, the percentage of leukocytes were
similar to the ones of the healthy portion of the tissue and signiﬁcantly
lower than in Ctr at day 14 in the areas 1–4, and at day 28 in the areas 3–
5 (Fig. 3B, p b 0.05). The percentage of CD68-positive cells was similar
between Ctr and oAEC treated tendons at day 7 (Fig. 3C, p N 0.05). Onthe contrary, at day 14 and 28 it was lower in allotransplanted tissues
than Ctr ones in most of the areas (Fig. 3C, p b 0.05).3.4. M1Mφ and M2Mφ related gene expression during tendon healing
In order to study the activation state of the Mφ during the early
phase of tendon healing, the expression of CD86, IL12b genes associated
with pro-inﬂammatory M1Mφ and CD206, IL10, YM1 genes associated
with anti-inﬂammatory and pro-reparative M2Mφ phenotype was de-
termined by RT-PCR (Fig. 4 and Fig. 5).
As summarized in Fig. 4, a progressive reduction of CD86mRNA ex-
pression was recorded in oAEC treated tendons. In detail, at day 7, CD86
mRNA levels were similar in both tendons to signiﬁcantly decrease at
day 14 and 28 only in oAEC treated tendons, whereas in the Ctr it
remained stable on high values during the early phase of healing
(Fig. 4A and B, p b 0.05). Moreover, IL12bmRNA expression was always
signiﬁcantly lower in oAEC treated tendons and even undetectable at
day 28 (Fig. 4A and B, p b 0.05). In Ctr tendons, a signiﬁcant reduction
of IL12b mRNA levels was exclusively observed at day 28 (Fig. 4A and
B, p b 0.05).
At day 7, YM1, CD206 and IL10were similarly expressed (Fig. 5A). At
day 14, CD206 and YM1 mRNA increased in both groups even if they
reached higher levels in oAEC transplanted tissues (Fig. 5B, p b 0.05).
On the contrary, at day 14 IL10mRNA level strongly increased exclusive-
ly in the presence of oAECs (Fig. 5B, p b 0.05). At day 28, the expression
of both CD206 and IL10 decreased in oAEC treated tendons which was
similar to the one observed in Ctr tendons. At this time, YM1 mRNA
level appeared to be signiﬁcantly lower in oAEC treated tendons than
in the Ctrs (Fig. 5B, p b 0.05).
Fig. 2.Morphological analysis of tendon healing. (A). H&E stain of injured Achilles tendon performed at 7, 14, and 28 days post treatment in Ctr (a–c) and oAEC treated tendons (d–f). The
healing portion and the healthy portion (asterisk) of tendon tissue are above and below the white line of the pictures, respectively. The images show a faster tissue organization in oAEC
treated tendons than in Ctr ones. oAECs, tendon allotransplantedwith amniotic epithelial cells; Ctr, contralateral tendon treatedwith onlyﬁbrin glue; H&E, hematoxylin and eosin staining.
Scale bar: 250 μm for all the images. (B). representative IHC images of COL1 (green color) expression performed at 28 days post treatment in Ctr (a) and oAEC treated tendons (b). The
images show a COL1 deposition and alignment in oAEC treated tendons respect to Ctr ones where COL1 expression is barely detectable. Nuclei were counterstained with DAPI (blue
color). Scale bar: 120 μm for all the images.
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anced towards M1 to M2 phenotype, the ratio of IL12b to IL10was also
considered. The lower IL12b:IL10 ratio in oAEC treated tendons con-
ﬁrmed a skewing towards M2Mφ phenotype during the early phase of
healing (Fig. 5B).
3.5. M1Mφ and M2Mφ tissue distribution during tendon healing
The presence and distribution of M1Mφ and M2Mφ subpopulations
were evaluated within the lesion site. In particular, the IHC analysis was
carried out to quantify and identify the pro-inﬂammatory M1Mφ phe-
notype (Fig. 6A–B) using the CD86 marker, whereas the pro-
reparative M2Mφ phenotype using the CD206 marker (Fig. 6C–D).
At day 7, M1Mφ inﬁltrationwas particularly high in the entire defect
zone of oAEC treated tendons (Fig. 6A). At day 14, the percentage of
CD86 positive cells dropped in oAEC treated tendons (Fig. 6A,
p b 0.05). Several CD86 positive cells (green marked) were recorded
close to several PKH26 (red marked) labeled cells (Fig. 6B: central and
bottom images) in the areas 3–4. Approximately 10% of them co-
localized with the PKH26 dye assuming a yellow merged ﬂuorescence(Fig. 6C: arrows bottom image). Most of the M1Mφ were localized in
the area 5 (Fig. 6A). Differently, in Ctr tendons the percentage of CD86
positive cells was always higher (Fig. 6A, p b 0.05), and evenly distribut-
ed within the lesion site (Fig. 6C: top image). At day 28, the percentage
ofM1Mφ in allotransplanted tendons further decreased reaching values
similar to those recorded into the healthy portion of the tendon. At this
time, the percentage of M1Mφ cells co-localizing with the red ﬂuores-
cence increased to ~35% of oAEC-PKH26 labeled cells. The percentage
of CD86 positive cells in Ctr tendon at day 28 resulted still signiﬁcantly
higher reaching values of approximately 20% in the whole defect area
(Fig. 6A, p b 0.05).
M2Mφ subpopulation, identiﬁed by the CD206 marker, displayed a
different behavior in oAEC treated and Ctr tendons. At day 7, the inﬁltra-
tion of M2Mφ was evident in the entire defect zone of both
allotransplanted and Ctr tendons (Fig. 6C). At this time, the percentage
of CD206 positive cells did not change in Ctr tissues (Fig. 6C), whereas it
signiﬁcantly raised in the areas 2–3 of oAEC treated ones (Fig. 6C,
p b 0.05). The M2Mφ cells localized in the areas 2–3 were recorded
close to the PKH26 positive cells and never co-localized the PKH26 red
ﬂuorescence (Fig. 6D: central and bottom images). At day 28, the
Fig. 3. Spatio-temporalmodiﬁcation of leukocyte andmacrophage inﬁltration.Quantiﬁcation of (A) cellularity, (B) leukocyte and (C)macrophage inﬁltration in healing tendonsperformed
at 7, 14, and 28 days post treatment. The data are presented as median ± 25° and 75° percentile of 15 determinations/area/animal performed at 200× of magniﬁcation by capturing ﬁve
images from six contiguous areas (indicated on x-axis as 0–5) starting from the healthy portion of the tissue (area 0) and proceeding throughout the repairing area (1–3) to the core of the
lesion (4–5). Each area analyzed was ~300 μm for an overall length of ~1800 μm. The ﬁnal data considered for each time point are the median of 90 different determinations (15
determination/area for 6 different animals/time point). Arrows indicated oAECs localization within the areas. *Signiﬁcantly different values between Ctr and oAECs treated tendon.
oAECs, transplanted tendons with amniotic epithelial cells; Ctr, contra lateral tendon treated with only ﬁbrin glue; cellularity, expressed as the total number of nuclei (DAPI stained) in
the area; leukocyte inﬁltration, expressed as percentage of CD45 positive cells/total number of nuclei in the area; macrophage inﬁltration, expressed as percentage of CD68 positive
cells/total number of nuclei in the area.
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areas 1–4 (Fig. 6B, p b 0.05) whereas it remained on high levels in the
core of the lesion (area 5, Fig. 6C).
4. Discussion
The present study demonstrates, for theﬁrst time, thatmacrophages
M1 andM2 phenotypes are recruited and differently distributed during
the early phase of tendon regeneration induced by oAECs allotransplan-
tation in an ovine tendon defect model with respect to Ctr tendons. In
particular, the presence of pro-regenerative M2Mφ phenotype subpop-
ulationswas strictly correlated to oAECs ability to induce tissue regener-
ation. This result allows us to speculate their immunomodulatory
properties also in an in vivo model, as it was already demostrated
in vitro (Barboni et al., 2014). Indeed, differently from Ctr tendons,
oAEC treated tendons showed a reduction of pro-inﬂammatory
M1Mφ, and the simultaneous recruitment of pro-regenerative M2Mφ
phenotype in the lesion site. Thismodulation onM1Mφ andM2Mφ sub-
populations was temporally related to the recovery of tissuemicroarchitecture recorded in allotransplanted oAEC treated tendons.
Similarly to lung model repairing after bleomycin-induced injury
model (Cargnoni et al., 2009; Moodley et al., 2010; Murphy et al.,
2011; Vosdoganes et al., 2013; Tan et al., 2014) or to hepatic ﬁbrosis res-
olution after CCL4 administration (Manuelpillai et al., 2012), also oAECs
allotransplantation in a tendon injury model could be involved in Mφ
polarization. It is reasonable to hypothesize that during tendon healing,
oAECs exhibit pleiotropic immune regulatory activities,which aremedi-
ated by complex mechanisms involving a spatial factors secretion that
inhibit the recruitment of leukocytes and the in situ activation/polariza-
tion of Mφ subpopulations. The recent immunomodulatory properties
of oAECs observed in vitro (Barboni et al., 2014) could explain the
in vivo oAECs allotransplantation effects. A conserved ability to inhibit
lymphocyte proliferation either in transwell co-culture or in cell-to-
cell contact systems was demonstrated in vitro (Barboni et al., 2014;
Magatti et al., 2014). However, in this research the in vivo oAECs immu-
nomodulatory property could be also strictly addressed to macrophage
recruitment, resulting an in situ activation of alternative M2Mφ, and a
simultaneous inhibition of classically M1Mφ phenotype during the
Fig. 4.M1macrophage related gene expression proﬁle in the defect area of healing tendons. (A) An example of RT-PCR images of CD86 and IL12bmRNA expression in Ctr and oAEC treated
tendons performed at 7, 14, and 28 days (d) post treatment. (B) Semiquantitative analysis normalized for GAPDH (values aremean of 3 replicates ± SD). §Signiﬁcantly different values in
the Ctr tendons during the different time points (p b 0.05); a a′Signiﬁcantly different values in the oAEC treated tendons during the different time points (p b 0.05); *Signiﬁcantly different
values between Ctr and oAEC treated tendons within each time point (p b 0.05).
Fig. 5.M2macrophage related geneexpression proﬁle in the defect area of healing tendons. (A) Anexample of RT-PCR images ofCD206, YM1 and IL10mRNAexpression performed at 7, 14,
and 28days (d) post treatment. (B) Semiquantitative analysis of genes normalized forGAPDH (values aremean of 3 replicates± SD). Ratio IL12b/IL10 indicated temporal skewing formM1
to M2 macrophages during the healing process. §, §′Signiﬁcantly different values in the Ctr tendons during the different time points (p b 0.05); a, a′Signiﬁcantly different values in oAEC
treated tendons during the different time points (p b 0.05); *Signiﬁcantly different values between Ctr and oAEC treated tendons within each time point (p b 0.05).
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seemed to be essential to drive the centripetal progression of tendon
healing and Mφ recruitment/activation. In fact, we have previously
demonstrated that tendon regeneration induced by oAECs begins from
the healthy portion of the tissue to invade progressively the core of
the wound site where the allotransplanted oAECs actively migrate
(Barboni et al., 2012a). Indeed, oAECs were always recorded close to
the front side of tissue regeneration contributing to growth factor,
such as VEGF and TGFβ1, and cytokine paracrine secretion. Thesemolecules induced host cell proliferation, blood vessel remodeling,
and collagen neo-deposition positively inﬂuencing the newly deposited
extracellular matrix organization and its orientation along the longitu-
dinal axis of the healthy tendon (Barboni et al., 2012a; Muttini et al.,
2013). Overall, these events led to an early tissue microarchitecture re-
covery of the injured tendon with a signiﬁcant improvement of its
biomechanical-proprieties (Barboni et al., 2012a). Tissue remodeling
was also supported by a direct oAEC trans-differentiation into tendon
like cells (Barboni et al., 2012a; Muttini et al., 2013). In the present re-
search when oAEC treated tendons began to recover their
microarchitecture, a simultaneous reduction of pro-inﬂammatory
M1Mφmarkers, mainly distributed close to AECs, and a drastic increase
of pro-regenerative M2Mφ markers, localized near the regenerating
areas, was evidenced, allowing to speculate an additional oAEC para-
crine effect towards the host tissue involving Mφ recruitment. The im-
portance of a local Mφ polarization during wound healing and tissue
regeneration is largely documented (Ariel et al., 2012; Gautier et al.,
2012; Manuelpillai et al., 2012; Abumaree et al., 2013; Davies et al.,
2013; Labonte et al., 2014; Tan et al., 2014). Even if the mechanisms in-
volved remain partially unknown, it has been widely recognized that
the secretion of anti-inﬂammatory cytokines and collagen degrading
enzymes from Mφ are frequently involved in tissue repair (Wynn and
Barron, 2010).Moreover, M2Mφ recruitment dependent on AECs trans-
plantation, has been recognized as a crucial anti-inﬂammatory and anti-
ﬁbrotic mechanism that supports lung and hepatic tissue repair
(Cargnoni et al., 2009; Manuelpillai et al., 2012; Abumaree et al., 2013;
Tan et al., 2014). Anti-inﬂammatory M2Mφ are polarized by speciﬁc in-
terleukins (IL4, IL10 and IL13) (Mosser and Edwards, 2008; Labonte
et al., 2014) some of them secreted in appreciable amounts by fetal
membranes (Williams et al., 2000; Bowen et al., 2002). Instead, the
pro-inﬂammatory M1Mφ are usually stimulated during the acute
phase of inﬂammation in response to interferon gamma IFNγ alone or
in combination withmicrobial or cytokines stimuli (e.g. Tumor necrosis
factor α) (Mosser and Edwards, 2008). Indeed, a massive presence of
pro-inﬂammatory M1Mφ subpopulation was observed at day 7 both
in oAEC treated and in Ctr tendons suggesting an ongoing inﬂammatory
state. However, starting from day 14, oAECs reduced the presence of
pro-inﬂammatory M1Mφ and promoted the anti-inﬂammatory and
pro-regenerative M2Mφ phenotype cells. Although pro-inﬂammatory
M1Mφ cells progressively decreased, severalM1Mφ cells were localized
amongst oAECs. In addition, it was observed that some pro-
inﬂammatory M1 CD86 positive cells co-localized with PKH26-oAECs
suggesting an active in situ phagocytosis process. Differently, theFig. 6. Spatio-temporal modiﬁcation of M1 and M2 macrophage subset populations.
Quantiﬁcation of (A) CD86 positive cell related to M1 macrophage and (C) CD206
positive cell related to M2 macrophage phenotypes in the defect area of healing tendons
performed at 7, 14, and 28 days post treatment. The data of quantiﬁcation are presented
as median ± 25° and 75° percentile of 15 determinations/area/animal performed at
200× of magniﬁcation by capturing ﬁve images from six contiguous areas (indicated on
x-axis as 0–5) starting from the healthy portion of the tissue (area 0) and proceeding
throughout the repairing zone (1–3) to the core of the lesion (4–5). The side of each
area analyzed was ~300 μm for an overall length of ~1800 μm. The ﬁnal data considered
for each time point are the median of 90 different determination (15 determination/area
for 6 different animals/time point). *Signiﬁcantly different values between Ctr and
oAECs treated tendon. oAECs, tendon transplanted with amniotic epithelial cells; Ctr,
contralateral tendon treated with only ﬁbrin glue; M1 macrophage subset inﬁltration
expressed as percentage of CD86 positive cells/total number of nuclei in the area; M2
macrophage subset inﬁltration, expressed as percentage of CD206 positive cells/total
number of nuclei in the area. Representative images of (B) CD86 positive cell and
(D) CD206 positive cells localization in Ctr (top image) and oAEC treated tendons at day
14 (central image). In the pictures PKH26-marked oAECs cells were visualized in red
color whereas CD86 or CD206 positive cells were visualized in green color. Nuclei were
counterstained with DAPI (blue color). Scale bar: 100 μm. In the inserts (B and D,
bottom images), details of oAECs PKH26-marked cells (red color) and CD86 (green
color) or CD206 positive cells (green color) localization in oAEC treated tendons,
respectively. Arrows, indicated some CD86 (green color) and PKH26 positive (red color)
cells co-localized giving a yellow merged ﬂuorescence. Scale bar: 35 μm.
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not present in thewhole repairing area, indeed this subset was spatially
limited to the areas actively involved in extracellular matrix deposition
and remodeling. This important Mφ spatial arrangement, and in partic-
ular of anti-inﬂammatoryM2Mφ subset,was demonstrated by adopting
sequential morphometric analyzes. This speciﬁc quantiﬁcation allowed
to describe oAECs centripetal repairingmechanism in situ that occurs in
the host-injured tendons. The presence ofM2Mφwas also conﬁrmed by
the analysis of the expression of their associated genes supporting the
hypothesis that oAECs modulate M2 polarization at day 14, exactly
when the allotransplanted tissue start to show a microarchitecture re-
covery. Indeed, the expression of M2 related cell surface marker
CD206 as well as YM1 and IL10 genes showed a peak two weeks later
oAECs transplantation. At day 28 oAECs treated tendons acquired a
healthy-like structure, and contextually presented a reduction of
M2Mφ phenotype cells and their markers, suggesting the ending of
their pro-regenerative role. On the contrary, Ctr tissues maintained a
high degree of disorganization and the pro-inﬂammatory M1Mφ
markers persistency, hypothesizing an ongoing inﬂammation that prob-
ably yield to ﬁbrotic scar formation. A rapid transition from the inﬂam-
matory to the reparative phase in oAECs allotransplanted tendons was
also supported by the lower IL12b and IL10 ratio indicating a Mφ
skewing towards M2 phenotype, accordingly to Manuelpillai et al.
(2012) observations in hAECs xeno-transplanted liver. This event ap-
peared to be highly conserved since it accompanied also theﬁbrosis res-
olution of lung experimentally induced diseases (Manuelpillai et al.,
2012; Abumaree et al., 2013; Moodley et al., 2013; Tan et al., 2014;
Vosdoganes et al., 2013). The higher expression of IL10 recorded at
day 14 in oAEC treated tendons represents per se a positive repairing ef-
fect since this cytokine functions as a broad anti-inﬂammatorymolecule
able to prevent the production of IL1, TNF-α, IL12 and other pro-
inﬂammatory factors (Fiorentino et al., 1991; D'Andrea et al., 1993;
Hedrich and Bream, 2010; Li et al., 2014). The contemporary spatial dis-
tribution of M2Mφ phenotype in the areas of newly matrix deposition,
strongly suggest that oAECs were able to orchestrate the complex ten-
don healing mechanisms. Indeed, according to Ariel and Timor (2013),
Mφ and oAECs may have a balancing role on tissue repair and ﬁbrosis
by contributing both to the in situ release of TGFβ and VEGF (Barboni
et al., 2012a), and of IL10, shown in this research. All these factors
may also inﬂuence matrix degrading enzymes such as metalloprotein-
ases MMPs and TIMPs inhibitors, all mediators involved in extracellular
matrix remodeling (Mantovani et al., 2013). Even if the cause–effect re-
lationship between oAECs and anti-inﬂammatoryM2Mφ during tendon
repair remains to be clariﬁed, it could be hypothesized that a normal
hostmacrophage function could be required for oAECs to exert their re-
parative effect. This assumption is supported by a recent work in which
hAECs transplanted in surfactant deﬁcient (Sftpc−/−) mice were un-
able to mitigate bleomicin induced lung injuries with impaired macro-
phage function (Murphy et al., 2012).
5. Conclusion
This study demonstrates that during the early phase of tendon re-
generation induced by oAECs allotransplantation, Mφ inﬁltration repre-
sents a key event, mainly promoting pro-inﬂammatory M1Mφ towards
anti-inﬂammatory and pro-regenerative M2Mφ phenotype skew.
oAECs, probably through paracrine effects, reduce the presence of in-
ﬂammatory CD45 and CD68 positive cells, and modulate M1Mφ and
M2Mφ balance and distribution supporting tissue regeneration. The
strict correlation between pro-regenerative M2Mφ distribution and
microarchitecture recovery allows us to hypothesize an additional
mechanism underlying oAECs mediated tendon healing. On the other
hand, the results provide further evidence of oAECs immunomodulatory
and anti-inﬂammatory effect supporting their pro-regenerative poten-
tial. Future studies should focus on the exact mechanisms by which
Mφ polarization is modulated by oAECs, as well as oAECs potential toinﬂuence other key immune cell types and reparative pathways during
tendon regeneration. In summary, these results give new insights into
Mφ involvement during tendon regeneration after oAECs allotransplan-
tation on a preclinical model. Overall, these results conﬁrm potential for
AEC-based regenerative therapies, and suggest cell-free alternative ap-
proaches that can respond to the clinical challenge related to animal
and human tendinopathy therapies.
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